Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Kimberly Clark Corp (KMB) Anymore

Page 1 of 2

Is Kimberly Clark Corp (NYSE:KMB) the right investment to pursue these days? The smart money is selling. The number of long hedge fund positions were cut by 1 lately.

To the average investor, there are many methods shareholders can use to watch stocks. A couple of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can trounce the broader indices by a superb margin (see just how much).

Kimberly Clark Corp (NYSE:KMB)Just as beneficial, bullish insider trading activity is a second way to parse down the investments you’re interested in. Obviously, there are plenty of incentives for an insider to downsize shares of his or her company, but only one, very obvious reason why they would behave bullishly. Many empirical studies have demonstrated the useful potential of this tactic if shareholders know where to look (learn more here).

Now, we’re going to take a look at the recent action encompassing Kimberly Clark Corp (NYSE:KMB).

How have hedgies been trading Kimberly Clark Corp (NYSE:KMB)?

Heading into Q2, a total of 20 of the hedge funds we track held long positions in this stock, a change of -5% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes considerably.

Of the funds we track, Diamond Hill Capital, managed by Ric Dillon, holds the biggest position in Kimberly Clark Corp (NYSE:KMB). Diamond Hill Capital has a $212.6 million position in the stock, comprising 2.2% of its 13F portfolio. Sitting at the No. 2 spot is Cliff Asness of AQR Capital Management, with a $108.3 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Remaining hedgies that hold long positions include David Harding’s Winton Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and Daniel S. Och’s OZ Management.

Due to the fact that Kimberly Clark Corp (NYSE:KMB) has experienced a declination in interest from the aggregate hedge fund industry, it’s safe to say that there exists a select few funds who sold off their full holdings last quarter. At the top of the heap, Phill Gross and Robert Atchinson’s Adage Capital Management dumped the largest position of the “upper crust” of funds we watch, valued at close to $22.9 million in stock., and Ray Dalio of Bridgewater Associates was right behind this move, as the fund sold off about $7.4 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest dropped by 1 funds last quarter.

How are insiders trading Kimberly Clark Corp (NYSE:KMB)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company we’re looking at has seen transactions within the past six months. Over the last six-month time period, Kimberly Clark Corp (NYSE:KMB) has seen zero unique insiders purchasing, and 8 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Kimberly Clark Corp (NYSE:KMB). These stocks are Energizer Holdings, Inc. (NYSE:ENR), The Procter & Gamble Company (NYSE:PG), Avon Products, Inc. (NYSE:AVP), Estee Lauder Companies Inc (NYSE:EL), and Colgate-Palmolive Company (NYSE:CL). All of these stocks are in the personal products industry and their market caps are similar to KMB’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!